ClinicalTrials.Veeva

Menu

Magnetic Resonance-Guided Adaptive Radiotherapy (MRgART) Using an Integrated Magnetic Resonance Linear Accelerator (MRL) (MRL1)

University Health Network, Toronto logo

University Health Network, Toronto

Status

Enrolling

Conditions

Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT04135794
19-5843

Details and patient eligibility

About

This study is being done to help further understand how MR-guided adaptive RT in conjunction with the Integrated Magnetic Resonance Linear Accelerator (MRL) can improve patient outcomes. This study will include participants who will be receiving radiotherapy using the MRL machine to target their cancer more precisely. Participants will be asked to have a few extra MR scans taken during their RT planning and to complete a few quality of life questionnaires.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients 18 years or older with a diagnosis of cancer, regardless of clinical site or stage
  • Planned to receive a course of MR-guided adaptive RT using the MRL
  • Ability to provide informed consent

Exclusion criteria

  • Patients under 18 years old

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems